Peer-reviewedCC BY-NC-NDBlood advances
Donor-targeted anti–HLA-A2 antibody shows nanogram-level efficacy in a novel GVHD mouse model
- 1Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
- 2SPARK Translational Research Program, Stanford University School of Medicine, Stanford, CA
- 3Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA
Related
- Phenotyping Antibody-mediated Rejection Without Detectable Donor-specific Antibodies 8 d After Heart Transplantation: A Case Study
- The Enferplex Bovine TB antibody test shows a significant degree of positivity in both restricted and officially tuberculosis free herds in a national study of bulk tank milk samples from dairy herds in Great Britain
- CD44-targeted near-infrared photoimmunotherapy shows potent anti-tumor effects in an orthotopic lung cancer model.
- Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials
- Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
BibTeX
@article{niizuma2026donortargeted,
title = {{Donor-targeted anti–HLA-A2 antibody shows nanogram-level efficacy in a novel GVHD mouse model}},
author = {Kouta Niizuma and Alyssa H. Chang and Yoshia Okamoto and Jeewon S. Kim and Kazunari Sasaki and Stephan Busque and Ravindra Majeti and Hiromitsu Nakauchi and Yusuke Nakauchi},
journal = {Blood advances},
year = {2026},
month = jul,
url = {https://europepmc.org/article/PMC/PMC13672817},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Donor-targeted anti–HLA-A2 antibody shows nanogram-level efficacy in a novel GVHD mouse model
AU - Kouta Niizuma
AU - Alyssa H. Chang
AU - Yoshia Okamoto
AU - Jeewon S. Kim
AU - Kazunari Sasaki
AU - Stephan Busque
AU - Ravindra Majeti
AU - Hiromitsu Nakauchi
AU - Yusuke Nakauchi
PY - 2026
DA - 2026/07/23
JO - Blood advances
UR - https://europepmc.org/article/PMC/PMC13672817
SN - 2473-9529
SN - 2473-9537
ER -